© 1999 by Oxford University Press
Journal of the National Cancer Institute, Vol. 91, No. 6, 500-501,
March 17, 1999
© 1999 Oxford University Press
NEWS |
New Standard of Care for Cervical Cancer Sets Stage For Next Questions
New data have resolved one of the major questions in cervical cancer treatment, as thousands
of oncologists learned last month in a special mailing from the National Cancer Institute.
NCI's "Clinical Announcement" only the fifth such mailing in the
Institute's history advised physicians that concurrent radiation and chemotherapy
with the drug cisplatin significantly extended survival in patients
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
P. J. Eifel Chemoradiotherapy for Cervical Cancer: What Next? J. Clin. Oncol., November 20, 2005; 23(33): 8277 - 8279. [Full Text] [PDF] |
||||
![]() |
P. J. Eifel, K. Winter, M. Morris, C. Levenback, P. W. Grigsby, J. Cooper, M. Rotman, D. Gershenson, and D. G. Mutch Pelvic Irradiation With Concurrent Chemotherapy Versus Pelvic and Para-Aortic Irradiation for High-Risk Cervical Cancer: An Update of Radiation Therapy Oncology Group Trial (RTOG) 90-01 J. Clin. Oncol., March 1, 2004; 22(5): 872 - 880. [Abstract] [Full Text] [PDF] |
||||
